! The Capitol Complex is open to the public with some limitations. All meetings are still available virtually online. Please visit the Capitol Information page for details.

Download Zipped Introduced WordPerfect HB0028.ZIP
[Status][Bill Documents][Fiscal Note][Bills Directory]

H.B. 28

             1     

CONTROLLED SUBSTANCE DATABASE

             2     
AMENDMENTS

             3     
2010 GENERAL SESSION

             4     
STATE OF UTAH

             5     
Chief Sponsor: Bradley M. Daw

             6     
Senate Sponsor: Curtis S. Bramble

             7     
             8      LONG TITLE
             9      Committee Note:
             10          The Health and Human Services Interim Committee recommended this bill.
             11      General Description:
             12          This bill recodifies and amends provisions relating to the Controlled Substance
             13      Database and requires an individual who is licensed to prescribe a controlled substance,
             14      who is applying for a license, or who is renewing a license, to register to use the
             15      database and to take a tutorial and pass a test relating to the database and the
             16      prescribing of a controlled substance.
             17      Highlighted Provisions:
             18          This bill:
             19          .    defines terms;
             20          .    recodifies provisions relating to the Controlled Substance Database into a new
             21      chapter known as the Controlled Substance Database Act;
             22          .    modifies provisions relating to accessing database information for certain legal
             23      proceedings;
             24          .    requires an individual who is licensed to prescribe a controlled substance, who is
             25      applying for a license, or who is renewing a license to:
             26              .    register to use the database; and
             27              .    take a tutorial and pass a test relating to the database and the prescribing of


             28      controlled substances;
             29          .    describes the penalties that may be imposed by Division of Occupational and
             30      Professional Licensing (DOPL) on an individual who fails to comply with the
             31      requirements described in the preceding paragraph;
             32          .    requires DOPL to develop an online tutorial and test relating to the use of the
             33      database and the prescribing of a controlled substance;
             34          .    requires DOPL to impose a fee on an individual who takes the test described in this
             35      bill to pay the costs incurred by DOPL to fulfill the requirements described in this
             36      bill;
             37          .    grants rulemaking authority to DOPL; and
             38          .    makes technical changes.
             39      Monies Appropriated in this Bill:
             40          None
             41      Other Special Clauses:
             42          None
             43      Utah Code Sections Affected:
             44      AMENDS:
             45          26-1-36, as last amended by Laws of Utah 2008, Chapter 313
             46          58-17b-201, as last amended by Laws of Utah 2005, Chapter 248
             47          58-37-6, as last amended by Laws of Utah 2009, Chapters 42 and 183
             48          63J-1-602, as enacted by Laws of Utah 2009, Chapter 368
             49      ENACTS:
             50          58-37f-101, Utah Code Annotated 1953
             51          58-37f-102, Utah Code Annotated 1953
             52          58-37f-201, Utah Code Annotated 1953
             53          58-37f-202, Utah Code Annotated 1953
             54          58-37f-203, Utah Code Annotated 1953
             55          58-37f-301, Utah Code Annotated 1953
             56          58-37f-302, Utah Code Annotated 1953
             57          58-37f-401, Utah Code Annotated 1953
             58          58-37f-402, Utah Code Annotated 1953


             59          58-37f-501, Utah Code Annotated 1953
             60          58-37f-601, Utah Code Annotated 1953
             61          58-37f-602, Utah Code Annotated 1953
             62          58-37f-701, Utah Code Annotated 1953
             63      RENUMBERS AND AMENDS:
             64          58-37f-502, (Renumbered from 58-37-7.7, as last amended by Laws of Utah 2006,
             65      Chapter 46)
             66          58-37f-801, (Renumbered from 58-37-7.8, as enacted by Laws of Utah 2008, Chapter
             67      313)
             68      REPEALS:
             69          58-37-7.5, as last amended by Laws of Utah 2009, Chapter 41
             70     
             71      Be it enacted by the Legislature of the state of Utah:
             72          Section 1. Section 26-1-36 is amended to read:
             73           26-1-36. Duty to establish program to reduce deaths and other harm from
             74      prescription opiates used for chronic noncancer pain.
             75          (1) As used in this section, "opiate" means any drug or other substance having an
             76      addiction-forming or addiction-sustaining liability similar to morphine or being capable of
             77      conversion into a drug having addiction-forming or addiction-sustaining liability.
             78          (2) In addition to the duties listed in Section 26-1-30 , the department shall develop and
             79      implement a two-year program in coordination with the Division of Professional Licensing, the
             80      Utah Labor Commission, and the Utah attorney general, to:
             81          (a) investigate the causes of and risk factors for death and nonfatal complications of
             82      prescription opiate use and misuse in Utah for chronic pain by utilizing the Utah Controlled
             83      Substance Database created in Section [ 58-37-7.5 ] 58-37f-201 ;
             84          (b) study the risks, warning signs, and solutions to the risks associated with
             85      prescription opiate medications for chronic pain, including risks and prevention of misuse and
             86      diversion of those medications;
             87          (c) provide education to health care providers, patients, insurers, and the general public
             88      on the appropriate management of chronic pain, including the effective use of medical
             89      treatment and quality care guidelines that are scientifically based and peer reviewed; and


             90          (d) educate the public regarding:
             91          (i) the purpose of the Controlled Substance Database established in Section [ 58-37-7.5 ]
             92      58-37f-201 ; and
             93          (ii) the requirement that a person's name and prescription information be recorded on
             94      the database when the person fills a prescription for a schedule II, III, IV, or V controlled
             95      substance.
             96          (3) The department shall report on the development and implementation of the
             97      program required in Subsection (2) to the legislative Health and Human Services Interim
             98      Committee and the legislative Business and Labor Interim Committee no later than the
             99      November interim meetings in 2008 and 2009. Each report shall include:
             100          (a) recommendations on:
             101          (i) use of the Utah Controlled Substance Database created in Section [ 58-37-7.5 ]
             102      58-37f-201 to identify and prevent:
             103          (A) misuse of opiates;
             104          (B) inappropriate prescribing; and
             105          (C) adverse outcomes of prescription opiate medications;
             106          (ii) interventions to prevent the diversion of prescription opiate medications; and
             107          (iii) medical treatment and quality care guidelines that are:
             108          (A) scientifically based; and
             109          (B) peer reviewed; and
             110          (b) (i) a measure of results against expectations under the program as of the date of the
             111      report; and
             112          (ii) an analysis of the application of the program, use of the appropriated funds, and the
             113      impact and results of the use of the funds.
             114          (4) The report provided under Subsection (3) for the 2008 interim shall also provide a
             115      final cumulative analysis of the measurable effectiveness of the program implemented under
             116      this section.
             117          Section 2. Section 58-17b-201 is amended to read:
             118           58-17b-201. Board -- Membership -- Qualifications -- Terms.
             119          (1) There is created the Utah State Board of Pharmacy consisting of five pharmacists,
             120      one pharmacy technician, and one member of the general public.


             121          (a) The public member of the board shall be a Utah resident who:
             122          (i) is 21 years of age or older;
             123          (ii) has never been licensed to engage in the practice of pharmacy;
             124          (iii) has never been the spouse of a person licensed to engage in the practice of
             125      pharmacy;
             126          (iv) has never held any material financial interest in pharmacy practice; and
             127          (v) has never engaged in any activity directly related to the practice of pharmacy.
             128          (b) The licensed pharmacist and licensed pharmacy technician members of the board
             129      shall:
             130          (i) have been Utah residents continuously for at least three years;
             131          (ii) have at least five years experience in the practice of pharmacy in good standing
             132      with the division in Utah after licensure; and
             133          (iii) maintain licensure in good standing to engage in the practice of pharmacy or
             134      practice as a pharmacy technician in Utah for the duration of the appointment.
             135          (2) The board shall be appointed and serve in accordance with Section 58-1-201 .
             136          (3) The duties and responsibilities of the board are in accordance with Sections
             137      58-1-202 and 58-1-203 , and as required under Section [ 58-37-7.5 ] 58-37f-202 regarding the
             138      controlled substance database. In addition, the board shall designate an appropriate member on
             139      a permanent or rotating basis to:
             140          (a) assist the division in reviewing complaints concerning the unlawful or
             141      unprofessional conduct of a licensee; and
             142          (b) advise the division in its investigation of these complaints.
             143          (4) A board member who has, under Subsection (3), reviewed a complaint or advised
             144      in its investigation may be disqualified from participating with the board when the board serves
             145      as a presiding officer in an adjudicative proceeding concerning the complaint.
             146          (5) A board member may be removed in accordance with Subsection 58-1-201 (2)(e) or
             147      upon one of the following grounds:
             148          (a) refusal or inability for any reason of a board member to perform his duties as a
             149      member of the Board in an efficient, responsible, and professional manner;
             150          (b) misuse of appointment to obtain personal, pecuniary, or material gain or advantage
             151      for himself or another through such appointment; or


             152          (c) violation of the laws governing the practice of pharmacy or Chapter 37, Utah
             153      Controlled Substances Act.
             154          Section 3. Section 58-37-6 is amended to read:
             155           58-37-6. License to manufacture, produce, distribute, dispense, administer, or
             156      conduct research -- Issuance by division -- Denial, suspension, or revocation -- Records
             157      required -- Prescriptions.
             158          (1) (a) The division may adopt rules relating to the licensing and control of the
             159      manufacture, distribution, production, prescription, administration, dispensing, conducting of
             160      research with, and performing of laboratory analysis upon controlled substances within this
             161      state.
             162          (b) The division may assess reasonable fees to defray the cost of issuing original and
             163      renewal licenses under this chapter pursuant to Section 63J-1-504 .
             164          (2) (a) (i) Every person who manufactures, produces, distributes, prescribes, dispenses,
             165      administers, conducts research with, or performs laboratory analysis upon any controlled
             166      substance in Schedules II through V within this state, or who proposes to engage in
             167      manufacturing, producing, distributing, prescribing, dispensing, administering, conducting
             168      research with, or performing laboratory analysis upon controlled substances included in
             169      Schedules II through V within this state shall obtain a license issued by the division.
             170          (ii) The division shall issue each license under this chapter in accordance with a
             171      two-year renewal cycle established by rule. The division may by rule extend or shorten a
             172      renewal period by as much as one year to stagger the renewal cycles it administers.
             173          (b) Persons licensed to manufacture, produce, distribute, prescribe, dispense,
             174      administer, conduct research with, or perform laboratory analysis upon controlled substances in
             175      Schedules II through V within this state may possess, manufacture, produce, distribute,
             176      prescribe, dispense, administer, conduct research with, or perform laboratory analysis upon
             177      those substances to the extent authorized by their license and in conformity with this chapter.
             178          (c) The following persons are not required to obtain a license and may lawfully possess
             179      controlled substances under this section:
             180          (i) an agent or employee, except a sales representative, of any registered manufacturer,
             181      distributor, or dispenser of any controlled substance, if the agent or employee is acting in the
             182      usual course of the person's business or employment; however, nothing in this subsection shall


             183      be interpreted to permit an agent, employee, sales representative, or detail man to maintain an
             184      inventory of controlled substances separate from the location of the person's employer's
             185      registered and licensed place of business;
             186          (ii) a motor carrier or warehouseman, or an employee of a motor carrier or
             187      warehouseman, who possesses any controlled substance in the usual course of the person's
             188      business or employment; and
             189          (iii) an ultimate user, or any person who possesses any controlled substance pursuant to
             190      a lawful order of a practitioner.
             191          (d) The division may enact rules waiving the license requirement for certain
             192      manufacturers, producers, distributors, prescribers, dispensers, administrators, research
             193      practitioners, or laboratories performing analysis if consistent with the public health and safety.
             194          (e) A separate license is required at each principal place of business or professional
             195      practice where the applicant manufactures, produces, distributes, dispenses, conducts research
             196      with, or performs laboratory analysis upon controlled substances.
             197          (f) The division may enact rules providing for the inspection of a licensee or applicant's
             198      establishment, and may inspect the establishment according to those rules.
             199          (3) (a) Upon proper application, the division shall license a qualified applicant to
             200      manufacture, produce, distribute, conduct research with, or perform laboratory analysis upon
             201      controlled substances included in Schedules I through V, unless it determines that issuance of a
             202      license is inconsistent with the public interest. The division shall not issue a license to any
             203      person to prescribe, dispense, or administer a Schedule I controlled substance. In determining
             204      public interest, the division shall consider whether or not the applicant has:
             205          (i) maintained effective controls against diversion of controlled substances and any
             206      Schedule I or II substance compounded from any controlled substance into other than
             207      legitimate medical, scientific, or industrial channels;
             208          (ii) complied with applicable state and local law;
             209          (iii) been convicted under federal or state laws relating to the manufacture, distribution,
             210      or dispensing of substances;
             211          (iv) past experience in the manufacture of controlled dangerous substances;
             212          (v) established effective controls against diversion; and
             213          (vi) complied with any other factors that the division establishes that promote the


             214      public health and safety.
             215          (b) Licenses granted under Subsection (3)(a) do not entitle a licensee to manufacture,
             216      produce, distribute, conduct research with, or perform laboratory analysis upon controlled
             217      substances in Schedule I other than those specified in the license.
             218          (c) (i) Practitioners shall be licensed to administer, dispense, or conduct research with
             219      substances in Schedules II through V if they are authorized to administer, dispense, or conduct
             220      research under the laws of this state.
             221          (ii) The division need not require a separate license for practitioners engaging in
             222      research with nonnarcotic controlled substances in Schedules II through V where the licensee is
             223      already licensed under this [act] chapter in another capacity.
             224          (iii) With respect to research involving narcotic substances in Schedules II through V,
             225      or where the division by rule requires a separate license for research of nonnarcotic substances
             226      in Schedules II through V, a practitioner shall apply to the division prior to conducting
             227      research.
             228          (iv) Licensing for purposes of bona fide research with controlled substances by a
             229      practitioner considered qualified may be denied only on a ground specified in Subsection (4),
             230      or upon evidence that the applicant will abuse or unlawfully transfer or fail to safeguard
             231      adequately the practitioner's supply of substances against diversion from medical or scientific
             232      use.
             233          (v) Practitioners registered under federal law to conduct research in Schedule I
             234      substances may conduct research in Schedule I substances within this state upon furnishing the
             235      division evidence of federal registration.
             236          (d) Compliance by manufacturers, producers, and distributors with the provisions of
             237      federal law respecting registration, excluding fees, entitles them to be licensed under this
             238      chapter.
             239          (e) The division shall initially license those persons who own or operate an
             240      establishment engaged in the manufacture, production, distribution, dispensation, or
             241      administration of controlled substances prior to April 3, 1980, and who are licensed by the
             242      state.
             243          (4) (a) Any license pursuant to Subsection (2) or (3) may be denied, suspended, placed
             244      on probation, or revoked by the division upon finding that the applicant or licensee has:


             245          (i) materially falsified any application filed or required pursuant to this chapter;
             246          (ii) been convicted of an offense under this chapter or any law of the United States, or
             247      any state, relating to any substance defined as a controlled substance;
             248          (iii) been convicted of a felony under any other law of the United States or any state
             249      within five years of the date of the issuance of the license;
             250          (iv) had a federal license denied, suspended, or revoked by competent federal authority
             251      and is no longer authorized to engage in the manufacturing, distribution, or dispensing of
             252      controlled substances;
             253          (v) had the licensee's license suspended or revoked by competent authority of another
             254      state for violation of laws or regulations comparable to those of this state relating to the
             255      manufacture, distribution, or dispensing of controlled substances;
             256          (vi) violated any division rule that reflects adversely on the licensee's reliability and
             257      integrity with respect to controlled substances;
             258          (vii) refused inspection of records required to be maintained under this chapter by a
             259      person authorized to inspect them; or
             260          (viii) prescribed, dispensed, administered, or injected an anabolic steroid for the
             261      purpose of manipulating human hormonal structure so as to:
             262          (A) increase muscle mass, strength, or weight without medical necessity and without a
             263      written prescription by any practitioner in the course of the practitioner's professional practice;
             264      or
             265          (B) improve performance in any form of human exercise, sport, or game.
             266          (b) The division may limit revocation or suspension of a license to a particular
             267      controlled substance with respect to which grounds for revocation or suspension exist.
             268          (c) (i) Proceedings to deny, revoke, or suspend a license shall be conducted pursuant to
             269      this section and in accordance with the procedures set forth in Title 58, Chapter 1, Division of
             270      Occupational and Professional Licensing Act, and conducted in conjunction with the
             271      appropriate representative committee designated by the director of the department.
             272          (ii) Nothing in this Subsection (4)(c) gives the Division of Occupational and
             273      Professional Licensing exclusive authority in proceedings to deny, revoke, or suspend licenses,
             274      except where the division is designated by law to perform those functions, or, when not
             275      designated by law, is designated by the executive director of the Department of Commerce to


             276      conduct the proceedings.
             277          (d) (i) The division may suspend any license simultaneously with the institution of
             278      proceedings under this section if it finds there is an imminent danger to the public health or
             279      safety.
             280          (ii) Suspension shall continue in effect until the conclusion of proceedings, including
             281      judicial review, unless withdrawn by the division or dissolved by a court of competent
             282      jurisdiction.
             283          (e) (i) If a license is suspended or revoked under this Subsection (4), all controlled
             284      substances owned or possessed by the licensee may be placed under seal in the discretion of the
             285      division.
             286          (ii) Disposition may not be made of substances under seal until the time for taking an
             287      appeal has lapsed, or until all appeals have been concluded, unless a court, upon application,
             288      orders the sale of perishable substances and the proceeds deposited with the court.
             289          (iii) If a revocation order becomes final, all controlled substances shall be forfeited.
             290          (f) The division shall notify promptly the Drug Enforcement Administration of all
             291      orders suspending or revoking a license and all forfeitures of controlled substances.
             292          (5) (a) Persons licensed under Subsection (2) or (3) shall maintain records and
             293      inventories in conformance with the record keeping and inventory requirements of federal and
             294      state law and any additional rules issued by the division.
             295          (b) (i) Every physician, dentist, naturopathic physician, veterinarian, practitioner, or
             296      other person who is authorized to administer or professionally use a controlled substance shall
             297      keep a record of the drugs received by him and a record of all drugs administered, dispensed, or
             298      professionally used by him otherwise than by a prescription.
             299          (ii) A person using small quantities or solutions or other preparations of those drugs for
             300      local application has complied with this Subsection (5)(b) if the person keeps a record of the
             301      quantity, character, and potency of those solutions or preparations purchased or prepared by
             302      him, and of the dates when purchased or prepared.
             303          (6) Controlled substances in Schedules I through V may be distributed only by a
             304      licensee and pursuant to an order form prepared in compliance with division rules or a lawful
             305      order under the rules and regulations of the United States.
             306          (7) (a) A person may not write or authorize a prescription for a controlled substance


             307      unless the person is:
             308          (i) a practitioner authorized to prescribe drugs and medicine under the laws of this state
             309      or under the laws of another state having similar standards; and
             310          (ii) licensed under this chapter or under the laws of another state having similar
             311      standards.
             312          (b) A person other than a pharmacist licensed under the laws of this state, or the
             313      pharmacist's licensed intern, as required by Sections 58-17b-303 and 58-17b-304 , may not
             314      dispense a controlled substance.
             315          (c) (i) A controlled substance may not be dispensed without the written prescription of
             316      a practitioner, if the written prescription is required by the federal Controlled Substances Act.
             317          (ii) That written prescription shall be made in accordance with Subsection (7)(a) and in
             318      conformity with Subsection (7)(d).
             319          (iii) In emergency situations, as defined by division rule, controlled substances may be
             320      dispensed upon oral prescription of a practitioner, if reduced promptly to writing on forms
             321      designated by the division and filed by the pharmacy.
             322          (iv) Prescriptions reduced to writing by a pharmacist shall be in conformity with
             323      Subsection (7)(d).
             324          (d) Except for emergency situations designated by the division, a person may not issue,
             325      fill, compound, or dispense a prescription for a controlled substance unless the prescription is
             326      signed by the prescriber in ink or indelible pencil or is signed with an electronic signature of
             327      the prescriber as authorized by division rule, and contains the following information:
             328          (i) the name, address, and registry number of the prescriber;
             329          (ii) the name, address, and age of the person to whom or for whom the prescription is
             330      issued;
             331          (iii) the date of issuance of the prescription; and
             332          (iv) the name, quantity, and specific directions for use by the ultimate user of the
             333      controlled substance.
             334          (e) A prescription may not be written, issued, filled, or dispensed for a Schedule I
             335      controlled substance.
             336          (f) Except when administered directly to an ultimate user by a licensed practitioner,
             337      controlled substances are subject to the following restrictions:


             338          (i) (A) A prescription for a Schedule II substance may not be refilled.
             339          (B) A Schedule II controlled substance may not be filled in a quantity to exceed a
             340      one-month's supply, as directed on the daily dosage rate of the prescriptions.
             341          (ii) A Schedule III or IV controlled substance may be filled only within six months of
             342      issuance, and may not be refilled more than six months after the date of its original issuance or
             343      be refilled more than five times after the date of the prescription unless renewed by the
             344      practitioner.
             345          (iii) All other controlled substances in Schedule V may be refilled as the prescriber's
             346      prescription directs, but they may not be refilled one year after the date the prescription was
             347      issued unless renewed by the practitioner.
             348          (iv) Any prescription for a Schedule II substance may not be dispensed if it is not
             349      presented to a pharmacist for dispensing by a pharmacist or a pharmacy intern within 30 days
             350      after the date the prescription was issued, or 30 days after the dispensing date, if that date is
             351      specified separately from the date of issue.
             352          (v) A practitioner may issue more than one prescription at the same time for the same
             353      Schedule II controlled substance, but only under the following conditions:
             354          (A) no more than three prescriptions for the same Schedule II controlled substance may
             355      be issued at the same time;
             356          (B) no one prescription may exceed a 30-day supply;
             357          (C) a second or third prescription shall include the date of issuance and the date for
             358      dispensing; and
             359          (D) unless the practitioner determines there is a valid medical reason to the contrary,
             360      the date for dispensing a second or third prescription may not be fewer than 30 days from the
             361      dispensing date of the previous prescription.
             362          (vi) Each prescription for a controlled substance may contain only one controlled
             363      substance per prescription form and may not contain any other legend drug or prescription
             364      item.
             365          (g) An order for a controlled substance in Schedules II through V for use by an
             366      inpatient or an outpatient of a licensed hospital is exempt from all requirements of this
             367      Subsection (7) if the order is:
             368          (i) issued or made by a prescribing practitioner who holds an unrestricted registration


             369      with the federal Drug Enforcement Administration, and an active Utah controlled substance
             370      license in good standing issued by the division under this section, or a medical resident who is
             371      exempted from licensure under Subsection 58-1-307 (1)(c);
             372          (ii) authorized by the prescribing practitioner treating the patient and the prescribing
             373      practitioner designates the quantity ordered;
             374          (iii) entered upon the record of the patient, the record is signed by the prescriber
             375      affirming the prescriber's authorization of the order within 48 hours after filling or
             376      administering the order, and the patient's record reflects the quantity actually administered; and
             377          (iv) filled and dispensed by a pharmacist practicing the pharmacist's profession within
             378      the physical structure of the hospital, or the order is taken from a supply lawfully maintained by
             379      the hospital and the amount taken from the supply is administered directly to the patient
             380      authorized to receive it.
             381          (h) A practitioner licensed under this chapter may not prescribe, administer, or
             382      dispense a controlled substance to a child, without first obtaining the consent required in
             383      Section 78B-3-406 of a parent, guardian, or person standing in loco parentis of the child except
             384      in cases of an emergency. For purposes of this Subsection (7)(h), "child" has the same
             385      meaning as defined in Section 78A-6-105 , and "emergency" means any physical condition
             386      requiring the administration of a controlled substance for immediate relief of pain or suffering.
             387          (i) A practitioner licensed under this chapter may not prescribe or administer dosages
             388      of a controlled substance in excess of medically recognized quantities necessary to treat the
             389      ailment, malady, or condition of the ultimate user.
             390          (j) A practitioner licensed under this chapter may not prescribe, administer, or dispense
             391      any controlled substance to another person knowing that the other person is using a false name,
             392      address, or other personal information for the purpose of securing the controlled substance.
             393          (k) A person who is licensed under this chapter to manufacture, distribute, or dispense
             394      a controlled substance may not manufacture, distribute, or dispense a controlled substance to
             395      another licensee or any other authorized person not authorized by this license.
             396          (l) A person licensed under this chapter may not omit, remove, alter, or obliterate a
             397      symbol required by this chapter or by a rule issued under this chapter.
             398          (m) A person licensed under this chapter may not refuse or fail to make, keep, or
             399      furnish any record notification, order form, statement, invoice, or information required under


             400      this chapter.
             401          (n) A person licensed under this chapter may not refuse entry into any premises for
             402      inspection as authorized by this chapter.
             403          (o) A person licensed under this chapter may not furnish false or fraudulent material
             404      information in any application, report, or other document required to be kept by this chapter or
             405      willfully make any false statement in any prescription, order, report, or record required by this
             406      chapter.
             407          (8) (a) (i) Any person licensed under this chapter who is found by the division to have
             408      violated any of the provisions of Subsections (7)(k) through (7)(o) is subject to a penalty not to
             409      exceed $5,000. The division shall determine the procedure for adjudication of any violations in
             410      accordance with Sections 58-1-106 and 58-1-108 .
             411          (ii) The division shall deposit all penalties collected under Subsection (8)(a)(i) in the
             412      General Fund as a dedicated credit to be used by the division under Subsection [ 58-37-7.7 ]
             413      58-37f-502 (1).
             414          (b) Any person who knowingly and intentionally violates Subsections (7)(h) through
             415      (7)(j) is:
             416          (i) upon first conviction, guilty of a class B misdemeanor;
             417          (ii) upon second conviction, guilty of a class A misdemeanor; and
             418          (iii) on third or subsequent conviction, guilty of a third degree felony.
             419          (c) Any person who knowingly and intentionally violates Subsections (7)(k) through
             420      (7)(o) shall upon conviction be guilty of a third degree felony.
             421          (9) Any information communicated to any licensed practitioner in an attempt to
             422      unlawfully procure, or to procure the administration of, a controlled substance is not considered
             423      to be a privileged communication.
             424          Section 4. Section 58-37f-101 is enacted to read:
             425     
CHAPTER 37f. CONTROLLED SUBSTANCE DATABASE ACT

             426     
Part 1. General Provisions

             427          58-37f-101. Title.
             428          This chapter is known as the "Controlled Substance Database Act."
             429          Section 5. Section 58-37f-102 is enacted to read:
             430          58-37f-102. Definitions.


             431          (1) The definitions in Section 58-37-2 apply to this chapter.
             432          (2) As used in this chapter:
             433          (a) "Board" means the Utah State Board of Pharmacy created in Section 58-17b-201 .
             434          (b) "Database" means the controlled substance database created in this section.
             435          (c) "Database manager" means the person responsible for operating the database, or the
             436      person's designee.
             437          (d) "Health care facility" is as defined in Section 26-21-2 .
             438          (e) "Mental health therapist" is as defined in Section 58-60-102 .
             439          (f) "Pharmacy" or "pharmaceutical facility" is as defined in Section 58-17b-102 .
             440          (g) "Prospective patient" means an individual who:
             441          (i) is seeking medical advice, medical treatment, or medical services from a
             442      practitioner; and
             443          (ii) the practitioner described in Subsection (2)(g)(i) is considering accepting as a
             444      patient.
             445          (h) "Substance abuse treatment program" is as defined in Section 62A-2-101 .
             446          Section 6. Section 58-37f-201 is enacted to read:
             447     
Part 2. Controlled Substance Database

             448          58-37f-201. Controlled substance database -- Creation -- Purpose.
             449          (1) There is created within the division a controlled substance database.
             450          (2) The division shall administer and direct the functioning of the database in
             451      accordance with this chapter.
             452          (3) The division may, under state procurement laws, contract with another state agency
             453      or a private entity to establish, operate, or maintain the database.
             454          (4) The division shall, in collaboration with the board, determine whether to operate
             455      the database within the division or contract with another entity to operate the database, based
             456      on an analysis of costs and benefits.
             457          (5) The purpose of the database is to contain the data described in Section 58-37f-203
             458      regarding every prescription for a controlled substance dispensed in the state to any individual
             459      other than an inpatient in a licensed health care facility.
             460          (6) The division shall maintain the database in an electronic file or by other means
             461      established by the division to facilitate use of the database for identification of:


             462          (a) prescribing practices and patterns of prescribing and dispensing controlled
             463      substances;
             464          (b) practitioners prescribing controlled substances in an unprofessional or unlawful
             465      manner;
             466          (c) individuals receiving prescriptions for controlled substances from licensed
             467      practitioners, and who subsequently obtain dispensed controlled substances from a drug outlet
             468      in quantities or with a frequency inconsistent with generally recognized standards of dosage for
             469      that controlled substance; and
             470          (d) individuals presenting forged or otherwise false or altered prescriptions for
             471      controlled substances to a pharmacy.
             472          Section 7. Section 58-37f-202 is enacted to read:
             473          58-37f-202. Duties of board in relation to the database.
             474          The board shall advise the division regarding:
             475          (1) establishing, maintaining, and operating the database;
             476          (2) access to the database and how access is obtained; and
             477          (3) control of information contained in the database.
             478          Section 8. Section 58-37f-203 is enacted to read:
             479          58-37f-203. Submission, collection, and maintenance of data.
             480          (1) The pharmacist in charge of the drug outlet where a controlled substance is
             481      dispensed shall submit the data described in this section to the manager of the database:
             482          (a) in accordance with the requirements of this section;
             483          (b) in accordance with the procedures established by the division; and
             484          (c) in the format established by the division.
             485          (2) The pharmacist described in Subsection (1) shall, for each controlled substance
             486      dispensed by a pharmacist under the pharmacist's supervision other than those dispensed for an
             487      inpatient at a health care facility, submit to the manager of the database the following
             488      information:
             489          (a) the name of the prescribing practitioner;
             490          (b) the date of the prescription;
             491          (c) the date the prescription was filled;
             492          (d) the name of the individual for whom the prescription was written;


             493          (e) positive identification of the individual receiving the prescription, including the
             494      type of identification and any identifying numbers on the identification;
             495          (f) the name of the controlled substance;
             496          (g) the quantity of the controlled substance prescribed;
             497          (h) the strength of the controlled substance;
             498          (i) the quantity of the controlled substance dispensed;
             499          (j) the dosage quantity and frequency as prescribed;
             500          (k) the name of the drug outlet dispensing the controlled substance;
             501          (l) the name of the pharmacist dispensing the controlled substance; and
             502          (m) other relevant information as required by division rule.
             503          (3) (a) The division shall make rules, in accordance with Title 63G, Chapter 3, Utah
             504      Administrative Rulemaking Act, to establish the electronic format in which the information
             505      required under this section shall be submitted to the database manager.
             506          (b) The division shall ensure that the database system records and maintains for
             507      reference:
             508          (i) the identification of each individual who requests or receives information from the
             509      database;
             510          (ii) the information provided to each individual; and
             511          (iii) the date and time that the information is requested or provided.
             512          Section 9. Section 58-37f-301 is enacted to read:
             513     
Part 3. Access

             514          58-37f-301. Access to database.
             515          (1) The division shall make rules, in accordance with Title 63G, Chapter 3, Utah
             516      Administrative Rulemaking Act, to:
             517          (a) effectively enforce the limitations on access to the database as described in this
             518      part; and
             519          (b) establish standards and procedures to ensure accurate identification of individuals
             520      requesting information or receiving information without request from the database.
             521          (2) The database manager shall make information in the database available only to the
             522      following individuals, in accordance with the requirements of this chapter and division rules:
             523          (a) personnel of the division specifically assigned to conduct investigations related to


             524      controlled substance laws under the jurisdiction of the division;
             525          (b) authorized division personnel engaged in analysis of controlled substance
             526      prescription information as a part of the assigned duties and responsibilities of their
             527      employment;
             528          (c) employees of the Department of Health whom the director of the Department of
             529      Health assigns to conduct scientific studies regarding the use or abuse of controlled substances,
             530      provided that the identity of the individuals and pharmacies in the database are confidential and
             531      are not disclosed in any manner to any individual who is not directly involved in the scientific
             532      studies;
             533          (d) a licensed practitioner having authority to prescribe controlled substances, to the
             534      extent the information:
             535          (i) (A) relates specifically to a current or prospective patient of the practitioner; and
             536          (B) is sought by the practitioner for the purpose of:
             537          (I) prescribing or considering prescribing any controlled substance to the current or
             538      prospective patient;
             539          (II) diagnosing the current or prospective patient;
             540          (III) providing medical treatment or medical advice to the current or prospective
             541      patient; or
             542          (IV) determining whether the current or prospective patient:
             543          (Aa) is attempting to fraudulently obtain a controlled substance from the practitioner;
             544      or
             545          (Bb) has fraudulently obtained, or attempted to fraudulently obtain, a controlled
             546      substance from the practitioner;
             547          (ii) (A) relates specifically to a former patient of the practitioner; and
             548          (B) is sought by the practitioner for the purpose of determining whether the former
             549      patient has fraudulently obtained, or has attempted to fraudulently obtain, a controlled
             550      substance from the practitioner;
             551          (iii) relates specifically to an individual who has access to the practitioner's Drug
             552      Enforcement Administration identification number, and the practitioner suspects that the
             553      individual may have used the practitioner's Drug Enforcement Administration identification
             554      number to fraudulently acquire or prescribe a controlled substance;


             555          (iv) relates to the practitioner's own prescribing practices, except when specifically
             556      prohibited by the division by administrative rule;
             557          (v) relates to the use of the controlled substance database by an employee of the
             558      practitioner, described in Subsection (2)(e); or
             559          (vi) relates to any use of the practitioner's Drug Enforcement Administration
             560      identification number to obtain, attempt to obtain, prescribe, or attempt to prescribe, a
             561      controlled substance;
             562          (e) in accordance with Subsection (3)(a), an employee of a practitioner described in
             563      Subsection (2)(d), for a purpose described in Subsection (2)(d)(i) or (ii), if:
             564          (i) the employee is designated by the practitioner as an individual authorized to access
             565      the information on behalf of the practitioner;
             566          (ii) the practitioner provides written notice to the division of the identity of the
             567      employee; and
             568          (iii) the division:
             569          (A) grants the employee access to the database; and
             570          (B) provides the employee with a password that is unique to that employee to access
             571      the database in order to permit the division to comply with the requirements of Subsection
             572      58-37f-203 (3)(b) with respect to the employee;
             573          (f) a licensed pharmacist having authority to dispense a controlled substance to the
             574      extent the information is sought for the purpose of:
             575          (i) dispensing or considering dispensing any controlled substance; or
             576          (ii) determining whether a person:
             577          (A) is attempting to fraudulently obtain a controlled substance from the pharmacist; or
             578          (B) has fraudulently obtained, or attempted to fraudulently obtain, a controlled
             579      substance from the pharmacist;
             580          (g) federal, state, and local law enforcement authorities, and state and local
             581      prosecutors, engaged as a specified duty of their employment in enforcing laws:
             582          (i) regulating controlled substances; or
             583          (ii) investigating insurance fraud, Medicaid fraud, or Medicare fraud;
             584          (h) a mental health therapist, if:
             585          (i) the information relates to a patient who is:


             586          (A) enrolled in a licensed substance abuse treatment program; and
             587          (B) receiving treatment from, or under the direction of, the mental health therapist as
             588      part of the patient's participation in the licensed substance abuse treatment program described
             589      in Subsection (2)(h)(i)(A);
             590          (ii) the information is sought for the purpose of determining whether the patient is
             591      using a controlled substance while the patient is enrolled in the licensed substance abuse
             592      treatment program described in Subsection (2)(h)(i)(A); and
             593          (iii) the licensed substance abuse treatment program described in Subsection
             594      (2)(h)(i)(A) is associated with a practitioner who:
             595          (A) is a physician, a physician assistant, an advance practice registered nurse, or a
             596      pharmacist; and
             597          (B) is available to consult with the mental health therapist regarding the information
             598      obtained by the mental health therapist, under this Subsection (2)(h), from the database; and
             599          (i) an individual who is the recipient of a controlled substance prescription entered into
             600      the database, upon providing evidence satisfactory to the database manager that the individual
             601      requesting the information is in fact the individual about whom the data entry was made.
             602          (3) (a) A practitioner described in Subsection (2)(d) may designate up to three
             603      employees to access information from the database under Subsection (2)(e).
             604          (b) The division shall make rules, in accordance with Title 63G, Chapter 3, Utah
             605      Administrative Rulemaking Act, to establish background check procedures to determine
             606      whether an employee designated under Subsection (2)(e)(i) should be granted access to the
             607      database.
             608          (c) The division shall grant an employee designated under Subsection (2)(e)(i) access
             609      to the database, unless the division determines, based on a background check, that the
             610      employee poses a security risk to the information contained in the database.
             611          (d) The division may impose a fee, in accordance with Section 63J-1-504 , on a
             612      practitioner who designates an employee under Subsection (2)(e)(i), to pay for the costs
             613      incurred by the division to conduct the background check and make the determination
             614      described in Subsection (3)(b).
             615          (4) (a) An individual who is granted access to the database based on the fact that the
             616      individual is a licensed practitioner or a mental health therapist shall be denied access to the


             617      database when the individual is no longer licensed.
             618          (b) An individual who is granted access to the database based on the fact that the
             619      individual is a designated employee of a licensed practitioner shall be denied access to the
             620      database when the practitioner is no longer licensed.
             621          Section 10. Section 58-37f-302 is enacted to read:
             622          58-37f-302. Other restrictions on access to database.
             623          (1) A person who is a relative of a deceased individual is not entitled to access
             624      information from the database relating to the deceased individual based on the fact or claim
             625      that the person is:
             626          (a) related to the deceased individual; or
             627          (b) subrogated to the rights of the deceased individual.
             628          (2) Except as provided in Subsection (3), data provided to, maintained in, or accessed
             629      from the database that may be identified to, or with, a particular person is not subject to
             630      discovery, subpoena, or similar compulsory process in any civil, judicial, administrative, or
             631      legislative proceeding, nor shall any individual or organization with lawful access to the data
             632      be compelled to testify with regard to the data.
             633          (3) The restrictions described in Subsection (2) do not apply to a civil, judicial, or
             634      administrative action brought to enforce the provisions of this chapter.
             635          Section 11. Section 58-37f-401 is enacted to read:
             636     
Part 4. Registration and Training

             637          58-37f-401. Database registration required -- Penalties for failure to register.
             638          (1) Each individual who, on July 1, 2010, has a license to prescribe a controlled
             639      substance under Chapter 37, Utah Controlled Substances Act, but is not registered with the
             640      division to use the database shall, on or before September 30, 2010:
             641          (a) register with the division to use the database; and
             642          (b) participate in the online tutorial and pass the online test described in Section
             643      58-37f-402 .
             644          (2) Each individual who, on July 1, 2010, is registered with the division to use the
             645      database shall, on or before September 30, 2010, participate in the online tutorial and pass the
             646      online test described in Section 58-37f-402 .
             647          (3) An individual may not obtain or renew a license to prescribe a controlled substance


             648      under Chapter 37, Utah Controlled Substances Act, unless the individual registers with the
             649      division to use the database.
             650          (4) Beginning on July 1, 2010, in order to register to use the database, the individual
             651      registering must participate in the online tutorial and pass the online test described in Section
             652      58-37f-402 .
             653          (5) Failure by an individual to comply with the requirements of this section is grounds
             654      for the division to take the following actions in accordance with Section 58-1-401 :
             655          (a) refuse to issue a license to the individual;
             656          (b) refuse to renew the individual's license; or
             657          (c) revoke, suspend, restrict, or place on probation the license.
             658          Section 12. Section 58-37f-402 is enacted to read:
             659          58-37f-402. Online tutorial and test relating to the database -- Fees -- Rulemaking
             660      authority.
             661          (1) The division shall develop an online tutorial and an online test for registration to
             662      use the database that provides instruction regarding, and tests, the following:
             663          (a) the purpose of the database;
             664          (b) how to access and use the database;
             665          (c) the law relating to:
             666          (i) the use of the database; and
             667          (ii) the information submitted to, and obtained from, the database; and
             668          (d) basic knowledge that is important for all people who prescribe controlled
             669      substances to know in order to help ensure the health and safety of an individual to whom a
             670      controlled substance is prescribed.
             671          (2) The division shall design the test described in this section as follows:
             672          (a) an individual shall answer all of the questions correctly in order to pass the test;
             673          (b) an individual shall be permitted to immediately retake the portion of the test that
             674      the individual answers incorrectly as many times as necessary for the individual to pass the test;
             675      and
             676          (c) after an individual takes the test, the test software shall:
             677          (i) immediately inform the individual of the number of questions that were answered
             678      incorrectly;


             679          (ii) provide the correct answers;
             680          (iii) replay the portion of the tutorial that relates to the incorrectly answered questions;
             681      and
             682          (iv) ask the individual the incorrectly answered questions again.
             683          (3) The division shall design the tutorial and test so that it is possible to take the
             684      tutorial and complete the test in 20 minutes or less, if the individual answers all of the
             685      questions correctly on the first attempt.
             686          (4) The division shall ensure that the tutorial and test described in this section are fully
             687      functional and available for use online on or before July 1, 2010.
             688          (5) The division shall impose a fee, in accordance with Section 63J-1-504 , on an
             689      individual who takes the test described in this section, to pay the costs incurred by the division
             690      to:
             691          (a) develop, implement, and administer the tutorial and test described in this section;
             692      and
             693          (b) fulfill the other duties imposed on the division under this part.
             694          (6) The division may make rules, in accordance with Title 63G, Chapter 3, Utah
             695      Administrative Rulemaking Act, to:
             696          (a) develop, implement, and administer the tutorial and test described in this
             697          section; and
             698          (b) fulfill the other duties imposed on the division under this part.
             699          Section 13. Section 58-37f-501 is enacted to read:
             700     
Part 5. Costs and Funding

             701          58-37f-501. Costs of operating database and recording and submitting data.
             702          (1) All department and division costs necessary to establish and operate the database
             703      shall be funded by appropriations from:
             704          (a) the Commerce Service Fund; and
             705          (b) the General Fund.
             706          (2) All costs associated with recording and submitting data as required in this chapter
             707      shall be assumed by the submitting pharmacy.
             708          Section 14. Section 58-37f-502 , which is renumbered from Section 58-37-7.7 is
             709      renumbered and amended to read:


             710           [58-37-7.7].     58-37f-502. Use of dedicated credits -- Controlled Substance
             711      Database -- Collection of penalties.
             712          (1) The director may use the monies deposited in the General Fund as a dedicated
             713      credit under Subsections 58-37-6 (8)(a), [58-37-7.5 (11)(c), and 58-37-7.5 (12)(b)]
             714      58-37f-601 (3)(d), and 58-37f-602 (2) for the following purposes:
             715          (a) maintenance and replacement of the database equipment, including hardware and
             716      software;
             717          (b) training of staff; and
             718          (c) pursuit of external grants and matching funds.
             719          (2) The director of the division may collect any penalty imposed under Subsections
             720      58-37-6 (8)(a), [ 58-37-7.5 (11)(c), and 58-37-7.5 (12)(b)] 58-37f-601 (3)(d), and 58-37f-602 (2)
             721      and which is not paid by:
             722          (a) referring the matter to the Office of State Debt Collection or a collection agency; or
             723          (b) bringing an action in the district court of the county in which the person owing the
             724      debt resides or in the county where the office of the director is located.
             725          (3) The director may seek legal assistance from the attorney general or the county or
             726      district attorney of the district in which the action is brought to collect the fine.
             727          (4) The court shall award reasonable [attorney's] attorney fees and costs to the division
             728      for successful collection actions under Subsection (2)(b).
             729          (5) All funding of the [controlled substance] database [as defined under Section
             730      58-37-7.5 ] is nonlapsing.
             731          Section 15. Section 58-37f-601 is enacted to read:
             732     
Part 6. Penalties

             733          58-37f-601. Unlawful release or use of database information -- Criminal and Civil
             734      Penalties.
             735          (1) Any person who knowingly and intentionally releases any information in the
             736      database in violation of the limitations under Part 3, Access, is guilty of a third degree felony.
             737          (2) (a) Any person who obtains or attempts to obtain information from the database by
             738      misrepresentation or fraud is guilty of a third degree felony.
             739          (b) Any person who obtains or attempts to obtain information from the database for a
             740      purpose other than a purpose authorized by this chapter or by rule is guilty of a third degree


             741      felony.
             742          (3) (a) Except as provided in Subsection (3)(e), a person may not knowingly and
             743      intentionally use, release, publish, or otherwise make available to any other person any
             744      information obtained from the database for any purpose other than those specified in Part 3,
             745      Access.
             746          (b) Each separate violation of this Subsection (3) is a third degree felony and is also
             747      subject to a civil penalty not to exceed $5,000.
             748          (c) The procedure for determining a civil violation of this Subsection (3) shall be in
             749      accordance with Section 58-1-108 , regarding adjudicative proceedings within the division.
             750          (d) Civil penalties assessed under this Subsection (3) shall be deposited in the General
             751      Fund as a dedicated credit to be used by the division under Subsection 58-37f-502 (1).
             752          (e) Nothing in this Subsection (3) prohibits a person who obtains information from the
             753      database under Subsection 58-37f-301 (2)(d) or (e) from:
             754          (i) including the information in the person's medical chart or file for access by a person
             755      authorized to review the medical chart or file; or
             756          (ii) providing the information to a person in accordance with the requirements of the
             757      Health Insurance Portability and Accountability Act of 1996.
             758          Section 16. Section 58-37f-602 is enacted to read:
             759          58-37f-602. Failure by pharmacist to submit information -- Penalties.
             760          (1) The failure of a pharmacist in charge to submit information to the database as
             761      required under Section 58-37f-203 , after the division has submitted a specific written request
             762      for the information or when the division determines the individual has a demonstrable pattern
             763      of failing to submit the information as required, is grounds for the division to take the
             764      following actions in accordance with Section 58-1-401 :
             765          (a) refuse to issue a license to the individual;
             766          (b) refuse to renew the individual's license;
             767          (c) revoke, suspend, restrict, or place on probation the license;
             768          (d) issue a public or private reprimand to the individual;
             769          (e) issue a cease and desist order; and
             770          (f) impose a civil penalty of not more than $1,000 for each dispensed prescription
             771      regarding which the required information is not submitted.


             772          (2) Civil penalties assessed under Subsection (1)(f) shall be deposited in the General
             773      Fund as a dedicated credit to be used by the division under Subsection 58-37f-502 (1).
             774          (3) The procedure for determining a civil violation of this section shall be in
             775      accordance with Section 58-1-108 , regarding adjudicative proceedings within the division.
             776          Section 17. Section 58-37f-701 is enacted to read:
             777     
Part 7. Miscellaneous

             778          58-37f-701. Immunity from liability.
             779          An individual who has submitted information to the database in accordance with this
             780      section may not be held civilly liable for having submitted the information.
             781          Section 18. Section 58-37f-801 , which is renumbered from Section 58-37-7.8 is
             782      renumbered and amended to read:
             783     
Part 8. Pilot Program

             784           [58-37-7.8].     58-37f-801. Pilot program for real-time reporting for controlled
             785      substance database -- Statewide implementation.
             786          (1) [(a)] As used in this section:
             787          [(i)] (a) "Pilot area" means the areas of the state that the division determines to operate
             788      the pilot program in, under Subsection (3), which may include:
             789          [(A)] (i) the entire state; or
             790          [(B)] (ii) geographical areas within the state.
             791          [(ii)] (b) "Pilot program" means the pilot program described in this section.
             792          [(b) The definitions in Subsection 58-37-7.5 (1) apply to this section.]
             793          (2) There is established a pilot program for real-time reporting of data to, and access to
             794      data from, the database by a pharmacy, a pharmaceutical facility, or a prescribing practitioner
             795      beginning on July 1, 2008, and ending on July 1, 2010.
             796          (3) In addition to fulfilling the requirements [of Sections 58-37-7.5 and 58-37-7.7 ]
             797      relating to the database on a statewide basis, the division shall, in accordance with Subsection
             798      (4), upgrade, administer, and direct the functioning of the database in geographical areas
             799      specified by the division, or on a statewide basis, in a manner that provides for real-time
             800      reporting of information entered into, and accessed from, the database by a pharmacy or
             801      pharmaceutical facility.
             802          (4) The division shall, under state procurement laws, and with the technical assistance


             803      of the Department of Technology Services, contract with a private entity to upgrade, operate,
             804      and maintain the database in the pilot area.
             805          (5) (a) All provisions and requirements of the statewide database, described in
             806      [Sections 58-37-7.5 and 58-37-7.7 ] the other parts of this chapter, are applicable to the
             807      database in the pilot area, to the extent that they do not conflict with the requirements of this
             808      section.
             809          (b) For purposes of [Section 58-37-7.5 , Section 58-37-7.7 ] the other parts of this
             810      chapter, and this section, the database in the pilot area is considered part of the statewide
             811      database.
             812          (6) A pharmacy or pharmaceutical facility shall cooperate with the division, or the
             813      division's designee, to provide real-time submission of, and access to, information for the
             814      database:
             815          (a) in the pilot area; and
             816          (b) when the division implements the pilot program as a permanent program under
             817      Subsection (10), on a statewide basis.
             818          (7) The penalties and enforcement provisions described in [Sections 58-37-7.5 and
             819      58-37-7.7 ] the other parts of this chapter apply to enforce the provisions of this section in
             820      relation to a pharmacy or pharmaceutical facility that is located in, or operates in, the pilot area.
             821          (8) The division may make rules, in accordance with Title 63G, Chapter 3, Utah
             822      Administrative Rulemaking Act, to provide for the real-time reporting of, and access to,
             823      information in accordance with the requirements of this section.
             824          (9) During the Legislature's 2009 interim, the division shall report to the Health and
             825      Human Services Interim Committee regarding:
             826          (a) the implementation, operation, and impact of the pilot program established in this
             827      section;
             828          (b) the progress made by the division in implementing the pilot program on a statewide
             829      basis;
             830          (c) the advisability of, and projected costs of, implementing the pilot program on a
             831      statewide basis; and
             832          (d) the use of the database by prescribing practitioners.
             833          (10) The division shall, on or before July 1, 2010, implement the pilot program as a


             834      permanent program on a statewide basis.
             835          (11) (a) The division shall, through the private entity contracted with under Subsection
             836      (4), provide, free of charge, to a pharmacy or pharmaceutical facility that is required to comply
             837      with Subsection (6), software, software installation assistance, and training, that will enable the
             838      pharmacy or pharmaceutical facility to comply with Subsection (6).
             839          (b) Notwithstanding Subsection (11)(a), a pharmacy or pharmaceutical facility required
             840      to comply with Subsection (6) may, instead of accepting installation of the software provided
             841      by the division under Subsection (11)(a), modify its own software in order to comply with the
             842      requirements of Subsection (6), if the modification is made:
             843          (i) except as provided in Subsection (11)(d), at the expense of the pharmacy or
             844      pharmaceutical facility;
             845          (ii) in consultation with the division; and
             846          (iii) within six months after the division notifies the pharmacy or pharmaceutical
             847      facility, in writing, of the division's intention to install the software described in Subsection
             848      (11)(a).
             849          (c) The division shall, through the private entity contracted with under Subsection (4),
             850      cooperate with a pharmacy or pharmaceutical facility that is required to comply with
             851      Subsection (6), to ensure that the installation and operation of the software described in
             852      Subsection (11)(a), or the provision of information from the pharmacy or pharmaceutical
             853      facility to the database:
             854          (i) complies with the security standards described in 45 C.F.R. Parts 160, 162, and 164,
             855      Health Insurance Reform: Security Standards;
             856          (ii) does not interfere with the proper functioning of the pharmacy's or pharmaceutical
             857      facility's software or computer system; and
             858          (iii) in order to minimize changes in existing protocols, provides, to the extent
             859      practicable, for the transmission of data in the same manner that pharmacies currently transmit
             860      information to insurance companies.
             861          (d) The division may, within funds appropriated by the Legislature for this purpose,
             862      reimburse a pharmacy for all or part of the costs of the in-house programing described in
             863      Subsection (11)(b), if:
             864          (i) the pharmacy requests the reimbursement, in writing;


             865          (ii) the pharmacy provides proof of the costs for the in-house programming to the
             866      division;
             867          (iii) the pharmacy requests the reimbursement prior to a deadline established by the
             868      division; and
             869          (iv) except as provided in Subsection (11)(e), the division pays an equal reimbursement
             870      amount to each pharmacy that complies with Subsections (11)(d)(i) through (iii).
             871          (e) The division may reimburse a pharmacy described in Subsection (11)(d)(iv) for an
             872      amount that is less than the reimbursement paid to other pharmacies described in Subsection
             873      (11)(d)(iv), if:
             874          (i) the proof of costs for in-house programming provided by the pharmacy establishes a
             875      cost less than the amount reimbursed to the other pharmacies; and
             876          (ii) the amount reimbursed to the pharmacy is equal to the amount established by the
             877      proof of costs for in-house programming submitted by the pharmacy.
             878          (f) Notwithstanding any other provision of this section, the division may, by rule, allow
             879      up to 24 hours for the reporting of data to the database by a non-resident pharmacy, as defined
             880      in Section 58-17b-102 .
             881          Section 19. Section 63J-1-602 is amended to read:
             882           63J-1-602. Nonlapsing accounts and funds.
             883          (1) The following revenue collections, appropriations from a fund or account, and
             884      appropriations to a program are nonlapsing:
             885          (a) appropriations made to the Legislature and its committees;
             886          (b) funds collected by the grain grading program, as provided in Section 4-2-2 ;
             887          (c) the Salinity Offset Fund created in Section 4-2-8.5 ;
             888          (d) the Invasive Species Mitigation Fund created in Section 4-2-8.7 ;
             889          (e) funds collected by pesticide dealer license registration fees, as provided in Section
             890      4-14-3 ;
             891          (f) funds collected by pesticide applicator business registration fees, as provided in
             892      Section 4-14-13 ;
             893          (g) the Rangeland Improvement Fund created in Section 4-20-2 ;
             894          (h) funds deposited as dedicated credits under the Insect Infestation Emergency Control
             895      Act, as provided in Section 4-35-6 ;


             896          (i) the Percent-for-Art Program created in Section 9-6-404 ;
             897          (j) the Centennial History Fund created in Section 9-8-604 ;
             898          (k) the Uintah Basin Revitalization Fund, as provided in Section 9-10-108 ;
             899          (l) the Navajo Revitalization Fund created in Section 9-11-104 ;
             900          (m) the LeRay McAllister Critical Land Conservation Program created in Section
             901      11-38-301 ;
             902          (n) the Clean Fuels and Vehicle Technology Fund created in Section 19-1-403 ;
             903          (o) fees deposited as dedicated credits for hazardous waste plan reviews, as provided in
             904      Section 19-6-120 ;
             905          (p) an appropriation made to the Division of Wildlife Resources for the appraisal and
             906      purchase of lands under the Pelican Management Act, as provided in Section 23-21a-6 ;
             907          (q) award monies under the Crime Reduction Assistance Program, as provided under
             908      Section 24-1-19 ;
             909          (r) funds collected from the emergency medical services grant program, as provided in
             910      Section 26-8a-207 ;
             911          (s) fees and other funding available to purchase training equipment and to administer
             912      tests and conduct quality assurance reviews, as provided in Section 26-8a-208 ;
             913          (t) funds collected as a result of a sanction under Section 1919 of Title XIX of the
             914      federal Social Security Act, as provided in Section 26-18-3 ;
             915          (u) the Utah Health Care Workforce Financial Assistance Program created in Section
             916      26-46-102 ;
             917          (v) monies collected from subscription fees for publications prepared or distributed by
             918      the insurance commissioner, as provided in Section 31A-2-208 ;
             919          (w) monies received by the Insurance Department for administering, investigating
             920      under, and enforcing the Insurance Fraud Act, as provided in Section 31A-31-108 ;
             921          (x) certain monies received for penalties paid under the Insurance Fraud Act, as
             922      provided in Section 31A-31-109 ;
             923          (y) the fund for operating the state's Federal Health Care Tax Credit Program, as
             924      provided in Section 31A-38-104 ;
             925          (z) certain funds in the Department of Workforce Services' program for the education,
             926      training, and transitional counseling of displaced homemakers, as provided in Section


             927      35A-3-114 ;
             928          (aa) the Employment Security Administration Fund created in Section 35A-4-505 ;
             929          (bb) the Special Administrative Expense Fund created in Section 35A-4-506 ;
             930          (cc) funding for a new program or agency that is designated as nonlapsing under
             931      Section 36-24-101 ;
             932          (dd) the Oil and Gas Conservation Account created in Section 40-6-14.5 ;
             933          (ee) funds available to the State Tax Commission for purchase and distribution of
             934      license plates and decals, as provided in Section 41-1a-1201 ;
             935          (ff) certain fees for the cost of electronic payments under the Motor Vehicle Act, as
             936      provided in Section 41-1a-1221 ;
             937          (gg) certain fees collected for administering and enforcing the Motor Vehicle Business
             938      Regulation Act, as provided in Section 41-3-601 ;
             939          (hh) certain fees for the cost of electronic payments under the Motor Vehicle Business
             940      Regulation Act, as provided in Section 41-3-604 ;
             941          (ii) the Off-Highway Access and Education Restricted Account created in Section
             942      41-22-19.5 ;
             943          (jj) certain fees for the cost of electronic payments under the Motor Vehicle Act, as
             944      provided in Section 41-22-36 ;
             945          (kk) monies collected under the Notaries Public Reform Act, as provided under
             946      46-1-23 ;
             947          (ll) certain funds associated with the Law Enforcement Operations Account, as
             948      provided in Section 51-9-411 ;
             949          (mm) the Public Safety Honoring Heroes Restricted Account created in Section
             950      53-1-118 ;
             951          (nn) funding for the Search and Rescue Financial Assistance Program, as provided in
             952      Section 53-2-107 ;
             953          (oo) appropriations made to the Department of Public Safety from the Department of
             954      Public Safety Restricted Account, as provided in Section 53-3-106 ;
             955          (pp) appropriations to the Motorcycle Rider Education Program, as provided in Section
             956      53-3-905 ;
             957          (qq) fees collected by the State Fire Marshal Division under the Utah Fire Prevention


             958      and Safety Act, as provided in Section 53-7-314 ;
             959          (rr) the DNA Specimen Restricted Account created in Section 53-10-407 ;
             960          (ss) the minimum school program, as provided in Section 53A-17a-105 ;
             961          (tt) certain funds appropriated from the Uniform School Fund to the State Board of
             962      Education for new teacher bonus and performance-based compensation plans, as provided in
             963      Section 53A-17a-148 ;
             964          (uu) certain funds appropriated from the Uniform School Fund to the State Board of
             965      Education for implementation of proposals to improve mathematics achievement test scores, as
             966      provided in Section 53A-17a-152 ;
             967          (vv) the School Building Revolving Account created in Section 53A-21-401 ;
             968          (ww) monies received by the State Office of Rehabilitation for the sale of certain
             969      products or services, as provided in Section 53A-24-105 ;
             970          (xx) the State Board of Regents, as provided in Section 53B-6-104 ;
             971          (yy) certain funds appropriated from the General Fund to the State Board of Regents
             972      for teacher preparation programs, as provided in Section 53B-6-104 ;
             973          (zz) a certain portion of monies collected for administrative costs under the School
             974      Institutional Trust Lands Management Act, as provided under Section 53C-3-202 ;
             975          (aaa) certain surcharges on residence and business telecommunications access lines
             976      imposed by the Public Service Commission, as provided in Section 54-8b-10 ;
             977          (bbb) certain fines collected by the Division of Occupational and Professional
             978      Licensing for violation of unlawful or unprofessional conduct that are used for education and
             979      enforcement purposes, as provided in Section 58-17b-505 ;
             980          (ccc) the Nurse Education and Enforcement Fund created in Section 58-31b-103 ;
             981          (ddd) funding of the controlled substance database, as provided in Section [ 58-37-7.7 ]
             982      58-37f-502 ;
             983          (eee) the Certified Nurse Midwife Education and Enforcement Fund created in Section
             984      58-44a-103 ;
             985          (fff) funding for the building inspector's education program, as provided in Section
             986      58-56-9 ;
             987          (ggg) certain fines collected by the Division of Occupational and Professional
             988      Licensing for use in education and enforcement of the Security Personnel Licensing Act, as


             989      provided in Section 58-63-103 ;
             990          (hhh) the Professional Geologist Education and Enforcement Fund created in Section
             991      58-76-103 ;
             992          (iii) certain monies in the Water Resources Conservation and Development Fund, as
             993      provided in Section 59-12-103 ;
             994          (jjj) funds paid to the Division of Real Estate for the cost of a criminal background
             995      check for broker and sales agent licenses, as provided in Section 61-2-9 ;
             996          (kkk) the Utah Housing Opportunity Restricted Account created in Section 61-2-28 ;
             997          (lll) funds paid to the Division of Real Estate for the cost of a criminal background
             998      check for a mortgage loan license, as provided in Section 61-2c-202 ;
             999          (mmm) funds paid to the Division of Real Estate in relation to examination of records
             1000      in an investigation, as provided in Section 61-2c-401 ;
             1001          (nnn) certain funds donated to the Department of Human Services, as provided in
             1002      Section 62A-1-111 ;
             1003          (ooo) certain funds donated to the Division of Child and Family Services, as provided
             1004      in Section 62A-4a-110 ;
             1005          (ppp) the Mental Health Therapist Grant and Scholarship Program, as provided in
             1006      Section 62A-13-109 ;
             1007          (qqq) assessments for DUI violations that are forwarded to an account created by a
             1008      county treasurer, as provided in Section 62A-15-503 ;
             1009          (rrr) appropriations to the Division of Services for People with Disabilities, as provided
             1010      in Section 62A-5-102 ;
             1011          (sss) certain donations to the Division of Substance Abuse and Mental Health, as
             1012      provided in Section 62A-15-103 ;
             1013          (ttt) certain funds received by the Division of Parks and Recreation from the sale or
             1014      disposal of buffalo, as provided under Section 63-11-19.2 ;
             1015          (uuu) revenue for golf user fees at the Wasatch Mountain State Park, Palisades State
             1016      Park, or Jordan River State Park, as provided under Section 63-11-19.5 ;
             1017          (vvv) revenue for golf user fees at the Green River State Park, as provided under
             1018      Section 63-11-19.6 ;
             1019          (www) the Centennial Nonmotorized Paths and Trail Crossings Program created under


             1020      Section 63-11a-503 ;
             1021          (xxx) the Bonneville Shoreline Trail Program created under Section 63-11a-504 ;
             1022          (yyy) the account for the Utah Geological Survey, as provided in Section 63-73-10 ;
             1023          (zzz) the Risk Management Fund created under Section 63A-4-201 ;
             1024          (aaaa) the Child Welfare Parental Defense Fund created in Section 63A-11-203 ;
             1025          (bbbb) the Constitutional Defense Restricted Account created in Section 63C-4-103 ;
             1026          (cccc) a portion of the funds appropriated to the Utah Seismic Safety Commission, as
             1027      provided in Section 63C-6-104 ;
             1028          (dddd) funding for the Medical Education Program administered by the Medical
             1029      Education Council, as provided in Section 63C-8-102 ;
             1030          (eeee) certain monies payable for commission expenses of the Pete Suazo Utah
             1031      Athletic Commission, as provided under Section 63C-11-301 ;
             1032          (ffff) funds collected for publishing the Division of Administrative Rules' publications,
             1033      as provided in Section 63G-3-402 ;
             1034          (gggg) the appropriation to fund the Governor's Office of Economic Development's
             1035      Enterprise Zone Act, as provided in Section 63M-1-416 ;
             1036          (hhhh) the Tourism Marketing Performance Account, as provided in Section
             1037      63M-1-1406 ;
             1038          (iiii) certain funding for rural development provided to the Office of Rural
             1039      Development in the Governor's Office of Economic Development, as provided in Section
             1040      63M-1-1604 ;
             1041          (jjjj) certain monies in the Development for Disadvantaged Rural Communities
             1042      Restricted Account, as provided in Section 63M-1-2003 ;
             1043          (kkkk) appropriations to the Utah Science Technology and Research Governing
             1044      Authority, created under Section 63M-2-301 , as provided under Section 63M-3-302 ;
             1045          (llll) certain monies in the Rural Broadband Service Fund, as provided in Section
             1046      63M-1-2303 ;
             1047          (mmmm) funds collected from monthly offender supervision fees, as provided in
             1048      Section 64-13-21.2 ;
             1049          (nnnn) funds collected by the housing of state probationary inmates or state parole
             1050      inmates, as provided in Subsection 64-13e-104 (2);


             1051          (oooo) the Sovereign Lands Management account created in Section 65A-5-1 ;
             1052          (pppp) certain forestry and fire control funds utilized by the Division of Forestry, Fire,
             1053      and State Lands, as provided in Section 65A-8-103 ;
             1054          (qqqq) the Department of Human Resource Management user training program, as
             1055      provided in Section 67-19-6 ;
             1056          (rrrr) funds for the University of Utah Poison Control Center program, as provided in
             1057      Section 69-2-5.5 ;
             1058          (ssss) appropriations to the Transportation Corridor Preservation Revolving Loan
             1059      Fund, as provided in Section 72-2-117 ;
             1060          (tttt) appropriations to the Local Transportation Corridor Preservation Fund, as
             1061      provided in Section 72-2-117.5 ;
             1062          (uuuu) appropriations to the Tollway Restricted Special Revenue Fund, as provided in
             1063      Section 77-2-120 ;
             1064          (vvvv) appropriations to the Aeronautics Construction Revolving Loan Fund, as
             1065      provided in Section 77-2-122 ;
             1066          (wwww) appropriations to the State Park Access Highways Improvement Program, as
             1067      provided in Section 72-3-207 ;
             1068          (xxxx) the Traffic Noise Abatement Program created in Section 72-6-112 ;
             1069          (yyyy) certain funds received by the Office of the State Engineer for well drilling fines
             1070      or bonds, as provided in Section 73-3-25 ;
             1071          (zzzz) certain monies appropriated to increase the carrying capacity of the Jordan River
             1072      that are transferred to the Division of Parks and Recreation, as provided in Section 73-10e-1 ;
             1073          (aaaaa) certain fees for the cost of electronic payments under the State Boating Act, as
             1074      provided in Section 73-18-25 ;
             1075          (bbbbb) certain monies appropriated from the Water Resources Conservation and
             1076      Development Fund, as provided in Section 73-23-2 ;
             1077          (ccccc) the Lake Powell Pipeline Project Operation and Maintenance Fund created in
             1078      Section 73-28-404 ;
             1079          (ddddd) certain funds in the Water Development and Flood Mitigation Reserve
             1080      Account, as provided in Section 73-103-1 ;
             1081          (eeeee) certain funds appropriated for compensation for special prosecutors, as


             1082      provided in Section 77-10a-19 ;
             1083          (fffff) the Indigent Aggravated Murder Defense Trust Fund created in Section
             1084      77-32-601 ;
             1085          (ggggg) the Indigent Felony Defense Trust Fund created in Section 77-32-701 ;
             1086          (hhhhh) funds donated or paid to a juvenile court by private sources, as provided in
             1087      Subsection 78A-6-203 (c);
             1088          (iiiii) a state rehabilitative employment program, as provided in Section 78A-6-210 ;
             1089      and
             1090          (jjjjj) fees from the issuance and renewal of licenses for certified court interpreters, as
             1091      provided in Section 78B-1-146 .
             1092          (2) No revenue collection, appropriation from a fund or account, or appropriation to a
             1093      program may be treated as nonlapsing unless:
             1094          (a) it is expressly referenced by this section;
             1095          (b) it is designated in a condition of appropriation in the appropriations bill; or
             1096          (c) nonlapsing authority is granted under Section 63J-1-603 .
             1097          (3) Each legislative appropriations subcommittee shall review the accounts and funds
             1098      that have been granted nonlapsing authority under this section or Section 63J-1-603 .
             1099          Section 20. Repealer.
             1100          This bill repeals:
             1101          Section 58-37-7.5, Controlled substance database -- Pharmacy reporting
             1102      requirements -- Access -- Penalties.




Legislative Review Note
    as of 11-18-09 1:19 PM


Office of Legislative Research and General Counsel


[Bill Documents][Bills Directory]